Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridging therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback